The Effectiveness of NeuroBot in Alleviating Anxiety of Patients Undergoing Neurovascular Surgeries
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorChinese University of Hong Kong
About this trial
The goal of this randomized controlled trial is to investigate the effectiveness of NeuroBot in alleviating anxiety of patients undergoing neurovascular procedures. The main questions it aims to answer are:
Is NeuroBot effective in alleviating anxiety? Is NeuroBot effective in enhancing patients' procedure and disease-related knowledge? Is NeuroBot effective in enhancing patients' compliance to treatment? If there is a comparison group: Researchers will compare with standard perioperative education (control group) to see if there is any difference in results.
Participants will be invited to chat with the artificial intelligence based chatbot "NeuroBot" for 6 weeks, from the date of preoperative clinic visit till 4 weeks after the surgery. The participants are allowed to access the NeuroBot at anytime anywhere, to ask surgery- related questions at their discretion.
Eligibility criteria
Qualifiers
aged above 18 years;
scheduled for elective neuroendovascular surgery;
able to understand Chinese and read Chinese;
mobile device with internet capability.
Disqualifiers
identified cognitive impairment or have difficulty in understanding study procedures, following instructions, or providing informed consent;
prior exposure to health chatbot to acquire health-related information in previous 3 months;
have neurovascular surgeries before
Trial design
Treatments tested in this trial
- NeuroBot
- Standard Care (in control arm)
Treatment groups
146 Participants
are divided into 2 treatment groupsSponsors and collaborators
Chinese University of Hong Kong
Lead sponsor
The Hong Kong Polytechnic University
Collaborator
Hospital Authority, Hong Kong
Collaborator
Source ClinicalTrials.gov